TB prevention strategies and unanswered questions for pregnant and postpartum women living with HIV: the need for improved evidence

TB prevention strategies and unanswered questions for pregnant and postpartum women living with HIV: the need for improved evidence Jyoti S Mathad*, Sylvia M LaCourse* and Amita Gupta Corresponding author: Amita Gupta, Center for Clinical Global Health Education, Johns Hopkins University, 600 North Wolfe Street, Baltimore, Maryland 21287, USA. Tel: 410-502-7696. (agupta25@jhmi.edu) *These authors have contributed equally to the work.

[1]  G. Montepiedra,et al.  Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women. , 2019, The New England journal of medicine.

[2]  B. Richardson,et al.  Brief Report: High Programmatic Isoniazid Preventive Therapy (IPT) Use in Pregnancy Among HIV-Infected Women. , 2019, Journal of acquired immune deficiency syndromes.

[3]  M. Hughes,et al.  Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons , 2019, PLoS medicine.

[4]  R. Chaisson,et al.  One Month of Rifapentine plus Isoniazid to Prevent HIV‐Related Tuberculosis , 2019, The New England journal of medicine.

[5]  R. Chaisson,et al.  Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials , 2018, Annals of the American Thoracic Society.

[6]  M. Jansson,et al.  Performance of QuantiFERON-TB Gold Plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis- and HIV-endemic setting , 2018, PloS one.

[7]  K. Dooley,et al.  Poor Obstetric and Infant Outcomes in Human Immunodeficiency Virus-Infected Pregnant Women With Tuberculosis in South Africa: The Tshepiso Study , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  B. Richardson,et al.  Effect of Pregnancy on Interferon Gamma Release Assay and Tuberculin Skin Test Detection of Latent TB Infection Among HIV-Infected Women in a High Burden Setting , 2017, Journal of acquired immune deficiency syndromes.

[9]  R. Chaisson,et al.  Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons , 2016, AIDS.

[10]  D. Fitzgerald,et al.  Quantitative IFN-γ and IL-2 Response Associated with Latent Tuberculosis Test Discordance in HIV-infected Pregnant Women. , 2016, American journal of respiratory and critical care medicine.

[11]  S. Hernández-Díaz,et al.  Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  M. Kruijshaar,et al.  Risk of tuberculosis in pregnancy: a national, primary care-based cohort and self-controlled case series study. , 2012, American journal of respiratory and critical care medicine.

[13]  Amita Gupta,et al.  Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  R. Bollinger,et al.  Symptom screening among HIV-infected pregnant women is acceptable and has high negative predictive value for active tuberculosis. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Melissa R. Pfeiffer,et al.  Tuberculosis prevention for non-US-born pregnant women. , 2006, American journal of obstetrics and gynecology.